(0241–0271) RA – Diagnosis, Manifestations, and Outcomes Poster I

Poster abstract session.

Presentations:

• 1:00 PM – 3:00 PM Eastern Time

  Inequity in Disease Impact Between Male and Female Rheumatoid Arthritis Patients
  

  Abstract Poster Presenter: Gonul Koc, MD – Erasmus MC
• 1:00 PM – 3:00 PM Eastern Time

  Neural Networks for Distinguishing Rheumatoid Arthritis from Psoriatic Arthritis by Using Magnetic Resonance Imaging
  

  Abstract Poster Presenter: Lukas Folle, MSc – Friedrich-Alexander-Universität Erlangen Nürnberg
• 1:00 PM – 3:00 PM Eastern Time

  Real World Evidence of Treatment Effectiveness and Unfavorable Clinical Events for Elderly-onset Early Rheumatoid Arthritis in Japan: Results from the IORRA Study
  

  Abstract Poster Presenter: Naohiro Sugitani, MD – Tokyo Women's Medical University
• 1:00 PM – 3:00 PM Eastern Time

  Identification of Novel Response Predictors via Cardiovascular Biomarker Proteomic Analysis of Serum Samples from Patients with Early, Seropositive RA Treated with Abatacept or Adalimumab
  

  Abstract Poster Presenter: Jinqi LIU, PhD – Bristol Myers Squibb
• 1:00 PM – 3:00 PM Eastern Time

  Influence of Forced Vital Capacity Impairment on Treatment Selection and Outcomes in RA-ILD Patients Initiating a Biologic or Targeted-Synthetic DMARD
  

  Abstract Poster Presenter: Bryant England, MD, PhD, RhMSUS – University of Nebraska Medical Center
• 1:00 PM – 3:00 PM Eastern Time

  Comorbidity Clusters in Patients with Rheumatoid Arthritis Predict Survival Prognosis
  

  Abstract Poster Presenter: Cynthia S. Crowson, PhD – Mayo Clinic
• 1:00 PM – 3:00 PM Eastern Time

  Rheumatoid Arthritis as a Modifier of the Cognition-Daily Function Association
  

  Abstract Poster Presenter: Maria Vassilaki, MD, PhD, MPH – Mayo Clinic
• 1:00 PM – 3:00 PM Eastern Time

  Monocyte Chemoattractant Protein-1, Vascular Cell Adhesion Protein-1 and Asymmetric Dimethylarginine as Potential Biomarkers of Interstitial Lung Disease Associated with RA
  

  Abstract Poster Presenter: Veronica Pulito Cueto, PhD – IDIVAL
• 1:00 PM – 3:00 PM Eastern Time

  Identification of Distinct Peripheral Blood Myeloid Cell Subpopulations in Patients with Rheumatoid Arthritis-associated Interstitial Lung Disease
  

  Abstract Poster Presenter: Jill Poole, MD – University of Nebraska Medical Center
• 1:00 PM – 3:00 PM Eastern Time

  Temporal Trends and Risk of Rheumatoid Arthritis in Celiac Disease Patients: A Nationwide Population-based Study
  

  Abstract Poster Presenter: Brinda Basida, MD – Brown university/ Rhode Island Hospital
• 1:00 PM – 3:00 PM Eastern Time

  Performance of Fear Assessment in Inflammatory Rheumatic Diseases (FAIR) Questionnaire in a Cohort of Rheumatoid Arthritis Patients in Argentina
  

  Abstract Poster Presenter: Jose Simon Alcivar-Navarrete, MD – Hospital General de Agudos Dr. Enrique Tornu
• 1:00 PM – 3:00 PM Eastern Time

  Nuclear Factor of Activated T Cells Cytoplasmic 1 as a Potential Biomarker of Increased Cardiovascular Risk in Patients with Early Rheumatoid Arthritis
  

  Abstract Poster Presenter: Sara Remuzgo-Martinez, PhD – Research group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic bone Diseases of the Musculoskeletal System, IDIVAL, Hospital Universitario Marqués de Valdecillla
• 1:00 PM – 3:00 PM Eastern Time

  Mitochondrial Content in Skeletal Muscle of Individuals with Rheumatoid Arthritis Is Associated with Physical Activity Level
  

  Abstract Poster Presenter: Beatriz Hanaoka, MD, MSc – OSU
• 1:00 PM – 3:00 PM Eastern Time

  Evaluation of Patients with Rheumatoid Arthritis in Teleconsultation During the First Wave of the COVID-19 Pandemic
  

  Abstract Poster Presenter: Jérôme Avouac, MD, PhD – Université de Paris Cité
• 1:00 PM – 3:00 PM Eastern Time

  Lipids and Vascular Inflammation in Patients with RA Using Triple Therapy vs Methotrexate + TNFi: A Secondary Analysis of the TARGET Randomized Active Comparator Trial
  

  Abstract Poster Presenter: Katherine Liao, MD, MPH – Brigham and Women's Hospital
• 1:00 PM – 3:00 PM Eastern Time

  Is Abatacept as Effective and Safe in Rheumatoid Arthritis Patients with Previous Malignancy as in Those Without?
  

  Abstract Poster Presenter: Yosuke Kunishita, MD, PhD – Department of Rheumatology, Yokohama Minami Kyosai Hospital
• 1:00 PM – 3:00 PM Eastern Time

  Patients with ACPA-positive and ACPA-negative Rheumatoid Arthritis Show Different Circulating Auto-antibody Repertoires
  

  Abstract Poster Presenter: Kevin Cunningham, PhD – University of Minnesota
• 1:00 PM – 3:00 PM Eastern Time

  High Density Lipoprotein Bound miR-1246 Is Enriched in Patients with Rheumatoid Arthritis and Is Proinflammatory
  

  Abstract Poster Presenter: Qiong Wu, PhD – Vanderbilt University Medical Center
• 1:00 PM – 3:00 PM Eastern Time

  Rheumatoid Arthritis Associated Interstitial Lung Disease Across Continents
  

  Abstract Poster Presenter: Sascha Heckert, MD – Leiden University Medical Centre
• 1:00 PM – 3:00 PM Eastern Time

  Impact of Comorbidity on Disease Activity and Functional Status in Patients with Rheumatoid Arthritis Receiving Biologic DMARDs, a Longitudinal Analysis of the KOBIO-RA
  

  Abstract Poster Presenter: Ju Yeon Kim, MD – Seoul National University Hospital
• 1:00 PM – 3:00 PM Eastern Time

  Impacts of Poor Prognostic Factors in Rheumatoid Arthritis on Clinical Outcomes and Treatment Choices from an Observational Cohort of Korean Patients with Rheumatoid Arthritis
  

  Abstract Poster Presenter: You-Jung Ha, MD, PhD – Seoul National University Bundang Hospital
• 1:00 PM – 3:00 PM Eastern Time

  Machine Learning and Computational Pathology Can Reveal Synovial Pathotypes in Mice and Humans
  

  Abstract Poster Presenter: Richard Bell, PhD – Hospital for Special Surgery
• 1:00 PM – 3:00 PM Eastern Time

  Predictors of Fragility Fracture Amongst Patients with Rheumatoid Arthritis: An Observational Cohort Study
  

  Abstract Poster Presenter: Marwan Bukhari, PhD, FRCP – Rheumatology (Oxford)
• 1:00 PM – 3:00 PM Eastern Time

  DAS28 (disease Activity Score) Elevations in Patients with Rheumatoid Arthritis (RA) Who Have Comorbid Fibromyalgia Are Explained by Elevated Tender Joint Counts as Much as by Elevated Patient Global Assessment
  

  Abstract Poster Presenter: Sandhya shri Kannayiram, MD – John H Stroger Hospital of Cook County
• 1:00 PM – 3:00 PM Eastern Time

  Reasons for Early Discontinuation of Targeted Synthetic (ts) or Biologic (b) DMARDs; Chart Review of 20,343 Drug Episodes Given to Patients with Rheumatoid Arthritis
  

  Abstract Poster Presenter: Chris Adams, MD – Articularis Healthcare Group
• 1:00 PM – 3:00 PM Eastern Time

  In Patients with Rheumatoid Arthritis, Clinical Examination of the Feet Is Important for Understanding Individual Disease Burden, but Does Not Provoke a Change in Therapy in Most Cases
  

  Abstract Poster Presenter: Nicolai Leuchten, MD – University Clinical Center Carl Gustav Carus
• 1:00 PM – 3:00 PM Eastern Time

  Expression of Cytokine and Chemokine Genes in Patients with Clinically Suspect Arthralgia; A Longitudinal Study During Progression to Inflammatory Arthritis or Non-Progression
  

  Abstract Poster Presenter: Judith Heutz, MD, MSc – Erasmus Medical Center
• 1:00 PM – 3:00 PM Eastern Time

  Cancer Risk with Biologic and Targeted Synthetic DMARDs in Patients with Rheumatic Diseases and Previous Malignancy: Results from the BIOBADASER Register
  

  Abstract Poster Presenter: Juan Molina-Collada, MD – Hospital General Universitario Gregorio Marañón
• 1:00 PM – 3:00 PM Eastern Time

  Risks of Mortality in Elderly-onset Rheumatoid Arthritis: Analysis from the TRA Clinical Electronic Registry
  

  Abstract Poster Presenter: Ching-Tsai Lin, MD – Taichung Veterans’ General Hospital
• 1:00 PM – 3:00 PM Eastern Time

  Practical Cut-off Points for Using the Rheumatoid Arthritis Impact of Disease (RAID) Questionnaire in Remote Consult Triage
  

  Abstract Poster Presenter: Angelique Weel, MD – Maasstad Hopsital & Erasmus University
• 1:00 PM – 3:00 PM Eastern Time

  Lower mRNA-anti SARS-Cov2 Induced IgG Antibody Responses to S1, S2 and RBD May Result from a Delayed IgA and IgM Class Switch in Patients with Rheumatoid Arthritis
  

  Abstract Poster Presenter: Kristin Schmiedeberg, DSc – Kantonsspital St.Gallen
• 1:00 PM – 3:00 PM Eastern Time

  Risk of Vascular Events Under the Treatments with Janus Kinase Inhibitors in Patients with Rheumatoid Arthritis: An Analysis Using Japanese Health Insurance Database
  

  Abstract Poster Presenter: Eiichi Tanaka, MD, PhD – Division of Rheumatology, Department of Internal Medicine, Tokyo Women’s Medical University School of Medicine